AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Galanis, E Bateman, A Johnson, K Diaz, RM James, CD Vile, R Russell, SJ
Citation: E. Galanis et al., Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas, HUM GENE TH, 12(7), 2001, pp. 811-821

Authors: Galanis, E Vile, R Russell, SJ
Citation: E. Galanis et al., Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors, CR R ONC H, 38(3), 2001, pp. 177-192

Authors: Reid, T Galanis, E Abbruzzese, J Sze, D Andrews, J Romel, L Hatfield, M Rubin, J Kirn, D
Citation: T. Reid et al., Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase Itrial, GENE THER, 8(21), 2001, pp. 1618-1626

Authors: Galanis, E Goldberg, R Reid, J Atherton, P Sloan, J Pitot, H Rubin, J Adjei, AA Burch, P Safgren, SL Witzig, TE Ames, MM Erlichman, C
Citation: E. Galanis et al., Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2 '-deoxyuridine (IdUrd), ANN ONCOL, 12(5), 2001, pp. 701-707

Authors: Galanis, E Buckner, JC
Citation: E. Galanis et Jc. Buckner, Chemotherapy of brain tumors, CURR OP NEU, 13(6), 2000, pp. 619-625

Authors: Galanis, E Buckner, JC Novotny, P Morton, RF McGinnis, WL Dinapoli, R Schomberg, P O'Fallon, JR
Citation: E. Galanis et al., Efficacy of neuroradiological imaging, neurological examination, and symptom status in follow-up assessment of patients with high-grade gliomas, J NEUROSURG, 93(2), 2000, pp. 201-207

Authors: Papagelopoulos, PJ Galanis, E Frassica, FJ Sim, FH Larson, DR Wold, LE
Citation: Pj. Papagelopoulos et al., Primary fibrosarcoma of bone - Outcome after primary surgical treatment, CLIN ORTHOP, (373), 2000, pp. 88-103

Authors: Galanis, E Buckner, J
Citation: E. Galanis et J. Buckner, Chemotherapy for high-grade gliomas, BR J CANC, 82(8), 2000, pp. 1371-1380

Authors: Galanis, E Rubin, J
Citation: E. Galanis et J. Rubin, Intratumoral gene transfer of the HLA-B7 gene into colon carcinoma metastases, METH MOL M, 35, 2000, pp. 453-467

Authors: James, CD Galanis, E Frederick, L Kimmel, DW Cunningham, JM Atherton-Skaff, PJ O'Fallon, JR Jenkins, RB Buckner, JC Hunter, SB Olson, JJ Scheithauer, BW
Citation: Cd. James et al., Tumor suppressor gene alterations in malignant gliomas: Histopathological associations and prognostic evaluation, INT J ONCOL, 15(3), 1999, pp. 547-553

Authors: Galanis, E Hersh, EM Stopeck, AT Gonzalez, R Burch, P Spier, C Akporiaye, ET Rinehart, JJ Edmonson, J Sobol, RE Forscher, C Sondak, VK Lewis, BD Unger, EC O'Driscoll, M Selk, L Rubin, J
Citation: E. Galanis et al., Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: Phase I/II experience, J CL ONCOL, 17(10), 1999, pp. 3313-3323

Authors: Galanis, E Frytak, S Rowland, KM Sloan, JA Lennon, VA
Citation: E. Galanis et al., Neuronal autoantibody titers in the course of small-cell lung carcinoma and platinum-associated neuropathy, CANCER IMMU, 48(2-3), 1999, pp. 85-90
Risultati: 1-12 |